Better Science, Better Health: EUCOPE Sits at Ground Zero in the IP and Orphan Drug Debates
EpisodeDec 20, 201836m
EUCOPE is Europe’s principal trade body for small to medium-sized biotechnology companies working in areas often targeting orphan diseases. In this podcast we're joined by Alexander Natz, EUCOPE’s Secretary General, and Delphine Roulland, Senior Manager Public Affairs, to discuss the impact on their members of proposed EU policy changes related to intellectual property, as well as the EU's ongoing review of the orphan drug legislation.See omnystudio.com/listener for privacy information.
Top comments